Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 15 of 15 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/25/22
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 12/11/18
End: 06/02/23
Due: 06/02/24
Phase: N/A
Priority: Normal
Start: 11/08/21
End: 09/21/22
Due: 09/21/23
Phase: N/A
Priority: Normal
Start: 02/05/04
End: 02/02/22
Due: 02/02/23
Phase: N/A
Priority: Normal
Start: 11/17/22
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 09/30/21
End: 08/11/22
Due: 08/11/23
Phase: N/A
Priority: Normal
Start: 12/02/21
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 08/31/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/22/19
End: 10/20/21
Due: 10/20/22
Phase: N/A
Priority: Normal
Start: 04/03/18
End: 04/30/28
Due: 04/30/29
Phase: N/A
Priority: Normal
Start: 03/31/22
End: 12/31/26
Due: 12/31/27
Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 08/17/21
End: 04/08/22
Due: 04/08/23
Intraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 06/11/19
Due: 06/11/20
Phase: N/A
Priority: Normal
Start: 02/28/25
End: 01/31/28
Due: 01/31/29